Physician profile
Anna Agaronov
NPI 1730839010
$4,321.01
in general payments reported to CMS, 2019-2025
22 companies · $2,079 in 2025
The $2,079 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $88.90 · 2024: $2,153 · 2025: $2,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,099 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,099.12 |
| Education | $221.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $711.30 | 2024-2025 | |
| Genzyme Corporation | $610.13 | 2024-2025 | |
| Janssen Biotech, INC. | $480.85 | 2024-2025 | Tremfya |
| Amgen INC. | $454.14 | 2024-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $286.10 | 2024-2025 | Zoryve |
| Leo Pharma INC. | $260.70 | 2025 | Anzupgo |
| Ucb, INC. | $241.95 | 2024-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $154.34 | 2024-2025 | Cabtreo, Siliq, Arazlo |
| Novartis Pharmaceuticals Corporation | $145.01 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $141.68 | 2024 | Tremfya |
| Lilly USA, LLC | $131.79 | 2024-2025 | Taltz, Ebglyss |
| Incyte Corporation | $129.85 | 2023-2025 | Opzelura |
| Verrica Pharmaceuticals INC. | $121.01 | 2024 | Ycanth |
| Sanofi-Aventis U.S. LLC | $89.95 | 2024 | |
| Botanix Sb INC | $74.26 | 2025 | Sofdra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $57.52 | 2024 | Sotyktu |
| Pfizer INC. | $56.49 | 2025 | |
| Lnhc, INC | $55.44 | 2025 | Zelsuvmi |
| Convatec INC. | $36.36 | 2024 | |
| Galderma Laboratories, L.P. | $36.18 | 2024 | |
| Kyowa Kirin, INC. | $27.52 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $18.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Agaronov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.